Browsing: Weight Loss

A patient in Blackburn or Bolton who has spent eighteen months on a waiting list for a specialist weight management referral will not care much that a tablet approved this week can be swallowed without the ritual of fasting water and empty stomachs that governs its rivals. Convenience is not what stands between most people…

The 45-year-old ‘This Is Us’ actress said she considered several approaches before turning to medication

A new daily weight loss pill, made by the same pharmaceutical company that makes the Mounjaro jab has been approved for use in the UK

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete with rival Novo Nordisk’sWegovy pill in the U.K

A law student died in her university halls of residence after taking weight loss medication, an inquest heard

NEW YORK, Aug 10 (Reuters) – Hims & Hers Health posted a wider-than-expected second-quarter loss on Monday as the telehealth company’s shift to branded weight-loss drugs drove up costs, sending its shares down 6% in extended trading

The UK has become the first country in Europe to approve a new pill to help with weight loss and treat diabetes

NewscricketTo Achieve Virat Kohli-Like Physique, Are Indian Cricketers Turning To Weight-Loss Injections?

Strong growth led by weight loss and international expansion: Q2 revenue rose nearly 40% year over year to more than $753 million, supported by 300,000 new subscribers and the Eucalyptus acquisition. Hims & Hers raised its 2026 revenue outlook to $3.1 billion–$3.3 billion

The arrival of the CMS’sMedicare GLP-1 Bridgeprogram has redrawn the map of drug pricing for weight management, setting a new, predictable monthly price point that is rippling across pharmacies, manufacturers, and care models. Since July 1, 2026, eligible Medicare Part D beneficiaries can access certain GLP-1 medications for a $50 copay through a short-term CMS…